Chronic Periodontitis Clinical Trial
Official title:
Assessment of Pentraxin-3 Levels in Gingival Crevicular Fluid and Saliva in Periodontal Health and Disease
Subjects were selected from the outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Oral and Dental Medicine, Cairo University. Ten healthy control subjects presented with clinically healthy periodontium. Ten patients who had plaque induced gingivitis. Ten patients who had generalized chronic periodontitis. Ten patients who had generalised aggressive periodontitis. Pentraxin-3 levels were evaluated in GCF and saliva of all subjects included in this study with ELISA technique.
The study population consisted of 4 groups of forty patients selected as follows:
Group 1 - Healthy Controls:
Ten healthy control subjects presented with clinically healthy periodontium. Control
subjects had to meet the following criteria for inclusion: probing depth less than 3mm, no
clinical attachment loss, no bleeding on probing, with Gingival and Plaque index 0-1.
Group 2 - Plaque induced gingivitis patients:
Ten patients who had plaque induced gingivitis characterized by the presence of any of the
following clinical signs: redness and edema of the gingival tissue, bleeding upon
provocation, changes in contour and consistency, presence of calculus and/or plaque, with no
clinical attachment loss nor radiographic evidence of bone loss.
Group 3 - Chronic periodontitis group:
Ten chronic moderate to severe periodontitis patients selected according to the criteria
currently adopted by Armitage 1999. Moderate destruction is generally characterized by
periodontal probing depths up to 6 mm with clinical attachment loss of up to 4 mm. Advanced
destruction is generally characterized by periodontal probing depths greater than 6 mm with
attachment loss greater than 4 mm. Radiographic evidence of bone loss is apparent, Increased
tooth mobility may be present.
Group 4 - Aggressive periodontitis group:
Ten patients suffering generalized aggressive periodontitis, patients were less than 35
years of age and had generalized interproximal attachment loss affecting at least 3
permanent teeth other than the first molars and incisors with at least one site each with PD
and CAL >5 mm, Attachment loss occurs in pronounced episodic periods of destruction, and
there is familial aggregation (subjects were asked if they had at least one other member of
the family presenting or with a history of periodontal diseases).
GCF and saliva samples were collected for all patients. Pentraxin-3 levels were evaluated in
GCF and saliva of all subjects included in this study with ELISA technique.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A |